Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 645.50
Change Today 0.00 / 0.00%
Volume 0.0
As of 10:24 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yossi Maimon CPA, MBA

Chief Financial Officer, Vice President, Secretary and Treasurer, Protalix BioTherapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Mr. Yossi Maimon, CPA, MBA, has been the Chief Financial Officer, Vice President, Treasurer and Secretary of Protalix Biotherapeutics, Inc. since December 31, 2006. Mr. Maimon serves as the Chief Financial Officer of Global Operations of EngelInvest Group Ltd. He served as the Chief Financial Officer of Protalix Ltd., since October 15, 2006. He has over a decade of broad experience in corporate finance, accounting, taxation and SEC compliance. Mr. Maimon served as the ...

Read Full Background

Corporate Headquarters*

2 Snunit Street
Carmiel, -- 21000


Phone: 972 4 988 9488
Fax: 972 4 988 9489

Board Members Memberships*

There is no Board Members Memberships data available.


The City University of New York
Tel Aviv University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$524,090

Stock Options*

Restricted Stock Awards$205,244
All Other Compensation$74,493
Exercisable Options283,333
Unexercisable Options21,667
Total Number of Options305,000

Total Compensation*

Total Annual Cash Compensation$598,583
Total Short Term Compensation$524,090
Other Long Term Compensation$279,737
Total Calculated Compensation$859,997
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PLX:IT 645.50 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROTALIX BIOTHERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at